Skip to main content

Part of COSD user guide v10.2.8

Appendix and downloads

Current Chapter

Current chapter – Appendix and downloads


Appendix and downloads

Please select from the boxes below to view and download the relevant supporting documentation:


Appendix G: Timetable for implementation of COSD version 10.0

Submissions are accepted as follows for Version 9.0 and/or v10.0

Timetable for implementation table

Diagnosis month

data set

schema

Accepted MDT system submission format

January 2024

v9.0

v9.0

XML only

February 2024

v9.0

v9.0

XML only

March 2024

v9.0

v9.0

XML only

April 2024

v9.0 or v10.0

v9.0 or v10.0

XML only

May 2024

v9.0 or v10.0

v9.0 or v10.0

XML only

June 2024

v9.0 or v10.0

v9.0 or v10.0

XML only

July 2024

v10.0

v10.0

XML only

August 2024

v10.0

v10.0

XML only

September 2024

v10.0

v10.0

XML only

October 2024

v10.0

v10.0

XML only

November 2024

v10.0

v10.0

XML only

December 2024

v10.0

v10.0

XML only

January 2025

v10.0

v10.0

XML only

Notes:

  • it is important to remember that there is a 25 working day period (post the end of each diagnosis month) before data should be reported, therefore:
    • April's data would be reported June
    • May's data would be reported in July
    • June's data would be reported in August
  • both v9.0 and v10.0 can be submitted during this period, until the Trust updates its cancer information system
  • all Trusts must be submitting v10 from September 2024 onwards (July's data)

*Site specific stage items to be submitted from start of implementation

Additional notes:

Site specific stage additional notes table

Clinical site

Site specific staging classification

CNS - CTYA

Chang Staging System Stage

CTYA

International Staging System for Retinoblastoma

 

International Neuroblastoma Risk Group (INGR) Staging System

 

Pretext Staging System Stage

 

Wilms Tumour Stage

 

TNM Stage Grouping for Non CNS Germ Cell Tumours

Gynaecological

Final Figo Stage

Haematological

Ann Arbor Stage

 

Binet Stage

 

R-ISS Stage for Myeloma

Haem - CTYA

Ann Arbor Stage

 

Murphy (St Jude) Stage

 

Children’s Oncology Group (COG) Staging System Stage

 

Central Nervous System Involvement

Liver

Barcelona Clinic Liver Cancer (BCLC) Stage

Urological

Stage Grouping (Testicular) as defined by The Royal Marsden Hospital (RMH)  


Appendix H: referral scenarios

Referral information is required once for each cancer diagnosis and is completed by the Provider which diagnosed the cancer. This should therefore be recorded from the beginning of the referral pathway within the Provider which led to the cancer diagnosis. It will normally begin at the referral to outpatients from primary care, from emergency services or from another Provider.

Cancer Waiting Times only requires this information for 2ww and screening referrals but for COSD it is essential that details of the referral section of the pathway are recorded for all cases.

Data items from referral to first seen date

The following data items should be completed according to the scenarios following:

  • Priority Type Code
  • Source of Referral for Out-Patients
  • Date First Seen
  • Consultant Code
  • Organisation Code (Provider First Seen)
  • Scenarios

Scenario 1:

‘2 Week Wait and Screening Cases’:

  • details as covered by Cancer Waiting Times guidance

Scenario 2:

‘Patients Initially Referred To Out-Patients’:

  • ‘Source of Referral for Out-Patients’ will normally be
Scenario 2 'usual referral' table

National Code

National code definition

03

Referral from a general medical practitioner

92

Referral from a general dental practitioner

12

referral from a General Practitioner with an Extended Role (GPwER) or Dentist with
Enhanced Skills (DES)

  • if referred from another hospital
Scenario 2 'referred from another hospital' table

National Code

National code definition

05

referral from a consultant, other than in an Emergency Care Department

Scenario 3:

‘Patients Initially Seen as Emergencies but then referred to another consultant’:

  • ‘Source of Referral for Out-Patients’ will be either:
Scenario 3 'seen as emergency' table

National Code

National code definition

01

following an emergency admission

10

following an Emergency Care Attendance (including Minor Injuries, Walk In Centres and Urgent Treatment Centres)

04

referral from an Emergency Care Department (including Minor Injuries Units, Walk In Centres and Urgent Treatment Centres)

Date First Seen’:

  • will be the first out-patient appointment following the emergency presentation or the first consultation with the specialist if patient remained as an inpatient

‘Consultant Code’:

  • relates to ‘Date First Seen’ so will be the consultant who the patient was referred to following the emergency presentation

‘Organisation Code (Provider First Seen)’:

  • relates to the ‘Date First Seen’ so will be the organisation the patient was referred to following the emergency presentation

Scenario 4:

Where a patient’s cancer was initially diagnosed and first treated as an emergency:

Source of Referral for Out-Patients’:

  • will normally be one of the emergency codes above

‘Date First Seen’:

  • will be the date of the emergency first treatment

‘Consultant Code’:

  • relates to ‘Date First Seen’ so will be the consultant carrying out the first treatment

‘Organisation Code (Provider First Seen)’:

  • relates to the ‘Date First Seen’ so will be the organisation carrying out the first treatment

Scenario 5:

Where a patient’s cancer was an incidental finding of another treatment or process.

  • Source of Referral for Out-Patients’ will be
Scenario 5 'incidental finding of another treatment or process' table

National Code

National code definition

11

Other (not listed) - initiated by the consultant responsible for the ‘Consultant Out-Patient Episode’

  • 'Date First Seen' will be the date of the incidental finding

  • 'Consultant Code' relates to Date First Seen, so will be the consultant who made the incidental findings during another treatment or process

  • 'Organisation Code (Provider First Seen)' relates to the Date First Seen, so will be the organisation where the incidental findings were made

Data items for cancer specialist

The following data items should be completed according to the scenarios following:

  • ‘First Seen by Specialist Date (Cancer)’
  • ‘Organisation Code (Provider First Cancer Specialist)’

Scenario 1:

Patient was first seen by the appropriate cancer specialist. Use same details as ‘Date First Seen’ and ‘Organisation Code (Provider First Seen)’.

Scenario 2:

Initial referral was not to the appropriate cancer specialist. Record details for the first appointment with the appropriate cancer specialist to progress this cancer diagnosis.


Appendix I: Haematology proforma and collection guidance document

The following is a new proforma for v9 that shows which of the site specific data items are applicable to each haematological diagnosis group.

This can be used as a tool (by the clinical team) during MDT, to ensure capture of all relevant data items and to help the MDT coordinator input the clinically agreed data.

Last edited: 20 March 2025 11:31 am